Listen to the Story

All Eyes on Gilead

Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. Gilead Sciences took extraordinary steps to get ready for the moment. By Robert LangrethSee <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Listen to the most interesting reporting from this week in the world of business, finance, tech, and politics. Over the weekend, we'll share a mix of essays, reviews and other stories from Bloomberg's new Weekend Edition.